Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery

Biomaterials

Volumn 48, Issue , 2015, Pages 84-96

  Yang, Yang ^a   Yang, YanFang ^a   Xie, XiangYang ^a,b   Wang, ZhiYuan ^a   Gong, Wei ^a   Zhang, Hui ^a   Li, Ying ^a   Yu, FangLin ^a   Li, ZhiPing ^a   Mei, XingGuo ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Cell penetrating peptides; Near infrared (NIR) two photon photolysis; NGR targeted; Small interfering RNA

Indexed keywords

AMINO ACIDS; CARDIOVASCULAR SYSTEM; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; HISTOLOGY; INFRARED DEVICES; LIGHT SENSITIVE MATERIALS; LIPOSOMES; MAMMALS; MOLECULAR BIOLOGY; PEPTIDES; PHOTOLYSIS; PHOTONS; PHOTOSENSITIVITY; PHYSICOCHEMICAL PROPERTIES; RNA; TUMORS;

CELL-PENETRATING PEPTIDE; CIRCULATORY SYSTEMS; NGR-TARGETED; PHOTOSENSITIVE GROUPS; SMALL INTERFERING RNA; SYSTEMIC ADMINISTRATION; TARGETING DELIVERIES; TWO PHOTON;

TARGETED DRUG DELIVERY;

ASPARTYLGLYCYLARGININE; CELL PENETRATING PEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIGAND; LIPOSOME; MICROSOMAL AMINOPEPTIDASE; MYC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER THERAPY; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CELL TRANSPORT; DRUG DISTRIBUTION; ENDOCYTOSIS; FEMALE; FIBROSARCOMA; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ZETA POTENTIAL; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CHEMISTRY; NUDE MOUSE; PHOTON; TUMOR CELL LINE;

MUS;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; FEMALE; HUMANS; LIGANDS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGOPEPTIDES; PHOTONS; RNA, SMALL INTERFERING;

EID: 84924964682     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.01.030     Document Type: Article

References (30)

1. Vivès E., Schmidt J., Pèlegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 2008, 1786:126-138.
2. Vivès E. Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse to wild to go only to Troy?". JControl Release 2005, 109:77-85.
3. Huang Y., Jiang Y., Wang H., Wang J., Shin M.C., Byun Y., et al. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev 2013, 65:1299-1315.
4. Krate F., Abu Ajaj K., Warnecke A. Anticancer carrier-linked prodrugs in clinical trials. Expert Opin Investig Drugs 2007, 16:1037-1058.
5. Kocer A., Walko M., Meijberg W., Feringa B.L. Alight-actuated nanovalve derived from a channel protein. Science 2005, 309:755-758.
6. Shamay Y., Adar L., Ashkenasy G., David A. Light induced drug delivery into cancer cells. Biomaterials 2011, 32:1377-1386.
7. Yang Y., Yang Y.F., Xie X.Y., Cai X.S., Mei X.G. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. JDrug Target 2014, 1-10. early online.
8. Hansen M.B., Gaal E.V., Minten I., Storm G., Hest J.C.M., Löwik D.W.P.M. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes. JControl Release 2012, 164:87-94.
9. Weissleder R. Aclearer vision for invivo imaging. Nat Biotechnol 2001, 19:316-317.
10. Hambley T.W. Is anticancer drug development heading in the right direction?. Cancer Res 2009, 69:1259-1261.
11. Neveu P., Aujard I., Benbrahim C., Saux T.L., Allemand J.F., Vriz S., et al. Acaged retinoic acid for one- and two-photon excitation in zebraflish embryos. Angew Chem Int Ed 2008, 47:3744-3746.
12. Patchornik A., Amit B., Woodward R.B. Photosensitive protecting groups. JAm Chem Soc 1970, 92:6333-6335.
13. Dakin K., Li W.H. Cell membrane permeable esters of D-myo-inositol 1,4,5-trisphosphate. Cell Calcium 2007, 42:291-301.
14. Zhao J., Gover T.D., Muralidharan S., Auston D.A., Weinreich D., Kao J.P.Y. Caged vanilloid ligands for activation of TRPV1 receptors by 1- and 2-photon excitation. Biochemistry 2006, 45:4915-4926.
15. Brown E.B., Shear J.B., Adams S.R., Tsien R.Y., Webb W.W. Photolysis of caged calcium in femtoliter volumes using two-photon excitation. Biophys J 1999, 76:489-499.
16. Shigenaga A., Yamamoto J., Sumikawa Y., Furuta T., Otaka A. Development and photo-responsive peptide bond cleavage reaction of two-photon near-infrared excitation-responsive peptide. Tetrahedron Lett 2010, 51:2868-2871.
17. Fischer P.M., Zhelev N.Z., Wang S., Melville J.E., Fahraeus R., Lane D.P. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector penetratin. JPept Res 2000, 55:163-172.
18. Torchilin V.P. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007, 9:E128-E147.
19. Gao W., Xiang B., Meng T.T., Liu F., Qi X.R. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials 2013, 34:4137-4149.
20. Yang Y.F., Yang Y., Xie X.Y., Cai X.S., Zhang H., Gong W., et al. PEGylated liposomes with NGR ligand and heat-activable cell penetrating peptide-doxorubicin conjugate for tumor-specific therapy. Biomaterials 2014, 35:4368-4381.
21. Negussie A.H., Miller J.L., Reddy G., Drake S.K., Wood B.J., Dreher M.R. Synthesis and invitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. JControl Release 2010, 143:265-273.
22. Xiang B., Dong D.W., Shi N.Q., Gao W., Yang Z.Z., Cui Y., et al. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials 2013, 34:4137-4149.
23. Park S.J., Park W., Na K. Photo-activatable ternary complex based on a multifunctional shielding material for targeted shRNA delivery in cancer treatment. Biomaterials 2013, 34:8991-8999.
24. Dunne M., Zheng J., Rosenblat J., Jaffray D.A., Allen C. APN/CD 13-targeting as a strategy to alter the tumor accumulation of liposomes. JControl Release 2011, 154:298-305.
25. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives invivo. Biochim Biophys Acta 1991, 1066:29-36.
26. Zhang Y., Peng L., Mumper R.J., Huang L. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials 2013, 34:8459-8468.
27. Curnis F., Sacchi A., Borgna L., Magni F., Gasparri A., Corti A. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol 2000, 18:1185-1190.
28. Huang Y., Lin D., Jiang Q., Zhang W., Guo S., Xiao P., et al. Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery. Biomaterials 2012, 33:4653-4664.
29. Chen Y.C., Wu J.J., Huang L. Nanoparticles targeted with NGR motif deliver c-myc siRAN and doxorubicin for anticancer therapy. Mol Ther 2010, 18:828-834.
30. Williford J.M., Wu J., Ren Y., Archang M.M., Leong K.W., Mao H.Q. Recent advances in nanoparticle-mediated siRNA delivery. Annu Rev Biomed Eng 2014, 16:347-370.